Critical role of kallikrein in hereditary angioedema pathogenesis: A clinical trial of ecallantide, a novel kallikrein inhibitor

2007123 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Allergy and Clinical Immunology

Volume 120, Issue 2, pp. 416-422

Field-Weighted Citation Impact: 7.92